Jeffrey Marbach

Should treatments that improve peripheral perfusion take precedence over a focus on hemodynamics in cardiogenic shock management? We explore the evolving paradigm of shock care and why it’s time to rethink what truly matters jacc.org/doi/10.1016/j.… @benhibbertMDPhD

It’s currently associated with better outcomes. What I worry about more is targeting the lactate doesn’t necessarily mean outcomes are better. If it becomes a target ppl might do more things to normalize the lactate that actually harm patients. Don’t think it can happen -…

Special issue of @cardiacinterv just out with a sneak peak discussion of the @SCAI #DLC initiative. The full peer reviewed position statement will be out in @MyJSCAI during SCAI SHOCK Tampa! Sept 18-20 Link: citoday.com/articles/2025-… @Babar_Basir @agtruesdell @davebaran…

Grateful for the opportunity to present both a research abstract and a complex TAVR case at #NYValves2025 , a conference full of learning and inspiration. Thankful for the valuable mentorship of Dr Golwala @HarshGMD, Dr. Firas Zahr and @JAMarbach along the way!🫀@OHSUCardFellows

Oof. When you forget to remove the chatGPT intro to your job post.

📅 June 27 | 1–4 PM CT | Advanced HF Virtual Summit Join @American_Heart to explore treatment and access solutions for advanced heart failure patients. Speakers from UCSD, Baptist Memorial Hospital Memphis & OHSU hrt.mobi/AdvancedHFSumm… #HFSummit #advancedHF #HeartFailure

Not too much goin' on today, so I thought I'd tell you about a new paper just published in @NEJMEvidence, w/ @metrics52, @carolxmgao, and @rwyeh We explain why instrumental variable (IV) methods are essential for randomized trials of medical interventions that fail to play out…

MI deaths in cancer patients are declining but disparities remain. From 1999–2020, 100K+ deaths: • AAMR dropped from 4.01 → 1.33 • Highest risk: NH Black pts, rural areas, prostate/lung cancers • Men > Women Gains made, but equity gaps persist. #ACC25 @JAMarbach @OHSUNews

📘#SCAIMCSebook Highlight: Chapter 9 Patient Identification and Device Selection This chapter highlights tailored #MCS decisions for acute decompensated #HeartFailure and #MI. ➡️scaipro.scai.org/URL/MCSEbookSe… #ADHF #Cardiology @NavinKapur4 @JAMarbach @ChweichHaval @leahkosyakovsky

The #ShockwaveC2plus catheter has 120 IVL pulses. How do you spend yours? Hear Dr @JAMarbach from @OHSUCardio share how he used #All120 pulses to treat this heavily calcified Cx. Learn more about Shockwave C2+: shockwavemedical.com/clinicians/usa… US Rx only. ISI bit.ly/3iEq7fC

New work in @CircAHA on Mixed Cardiogenic Shock. The document proposes a Standardized Classification, a Hemodynamic Definition, and Framework for Management. Below is the proposed hemodynamic definition of cardio-vasodilatory shock. A thread ..... 1/5

We clearly need more dedicated #CICU trials of #VTstorm to learn how to treat these patients. It's like early days of cardiogenic shock. With @fdanielramirez we are doing the SEDATE trial looking at Precedex up front for treatment of VT storm and have started recruiting.

The new @SCAI MCS EBook is here (download below!) I had a great time bringing together ths best of both interventional and critical care (@JAMarbach @NavinKapur4 @ChweichHaval) to write about device selection in cardiogenic shock. scaipro.scai.org/URL/MCS-EBook

Please to share our 📜under the mentorship of @JAMarbach , We explores how complete revascularization compares to culprit-only revascularization in older adults (75+) in terms of restricted mean survival time. 🔗jacc.org/doi/10.1016/j.… @OHSUCardFellows

Almost a month into fellowship, we are so proud to have this amazing team of new @OHSUCardio fellows. We are really excited to keep learning with you✨🫀🤓

Congratulations ⁦@SalmanZahidMD⁩ Time-Varying Cardiovascular Effects of Complete Versus Culprit Vessel Revascularization Among Older Adults With Myocardial Infarction - ScienceDirect. ⁦@OHSUCardFellows⁩ sciencedirect.com/science/articl…

First 2 commercial #RDN cases in the NW USA. Thank you @Medtronic and @OHSUCardio

First DRAIN-HF enrollment in Oregon! Congratulations to @JAMarbach and the team at @OHSUCardio on enrolling your first patient in this groundbreaking study for patients with acute decompensated #heartfailure. #Aortix #cardiorenalsyndrome #diureticresistance #clinicaltrials…

Presenting at #ACC24 Interventional Cardiology section with Katie Lutz : We discuss the time-varying cardiovascular impact of complete revascularization vs. culprit-only revascularization in older adults. Grateful to Dr. Marbach @JAMarbach for his mentorship. @OHSUCardFellows